{"id":"W4416019293","doi":"10.1016/j.ijgc.2025.102245","title":"PEMBROLIZUMAB PLUS ADJUVANT CHEMOTHERAPY WITH OR WITHOUT RADIOTHERAPY FOR NEWLY DIAGNOSED HIGH-RISK ENDOMETRIAL CANCER: HEALTH-RELATED QUALITY OF LIFE (HRQOL) FROM THE PHASE 3 ENGOT-EN11/GOG-3053/KEYNOTE-B21 STUDY","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Pembrolizumab; Radiation therapy; Quality of life (healthcare); Chemotherapy; Adjuvant; Phases of clinical research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002158774,0.000772026,0.001547193,0.00030414,0.0002716618,0.0007775412,0.0004384723,0.0007891441,0.001722772],"category_scores_gemma":[0.001370364,0.0003529309,0.002992572,0.0004510427,0.000420481,0.0008938122,0.00042112,0.0018398,0.0002665279],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007847433,"about_ca_system_score_gemma":0.0008146957,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002094724,"about_ca_topic_score_gemma":0.006146536,"domain_scores_codex":[0.999332,0.0003390139,0.00004891016,0.00009571917,0.00006146596,0.0001228175],"domain_scores_gemma":[0.9993443,0.0001916647,0.000183891,0.00005281403,0.00003403137,0.0001931916],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8749394,0.007798494,0.0260821,0.001548321,0.01132371,0.0001123931,0.0001362706,0.002035473,0.004562646,0.000138234,0.002006678,0.06931629],"study_design_scores_gemma":[0.5127584,0.2171455,0.2376563,0.000496957,0.02135162,0.0002648727,0.0002575771,0.001774776,0.00149626,0.0004215094,0.006291845,0.000084308],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9884828,0.00803076,0.0002650617,0.0003283862,0.0001253699,0.0003659902,0.00141371,0.00001323976,0.0009746176],"genre_scores_gemma":[0.9922314,0.003382958,0.0003888589,0.0007406348,0.0001195208,0.0003693255,0.002100374,0.000008699753,0.0006582431],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002158774,"threshold_uncertainty_score":0.01141685,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08763137003118326,"score_gpt":0.4690589906847477,"score_spread":0.3814276206535644,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}